GlaxoSmithKline PLC Director/PDMR Shareholding (3317I)
11 August 2021 - 9:34PM
UK Regulatory
TIDMGSK
RNS Number : 3317I
GlaxoSmithKline PLC
11 August 2021
GlaxoSmithKline plc (the ' Company ')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
==== ===========================================================================================
a) Name Dr H Barron
==== ======================================== =================================================
b) Position/status Chief Scientific Officer and President,
R&D
==== ======================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===========================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===========================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial
instrument ISIN: US37733W1053
==== ======================================== =================================================
b) Nature of the Acquisition of notional ADSs within Dr
transaction Barron's GSK Executive Supplemental Savings
Plan account
==== ======================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ===================== =======================
$40.58 1,141.045
===================== =======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
========================================= =====================================================
e) Date of the transaction 2021-08-09
==== ======================================== =================================================
f) Place of the New York Stock Exchange (XNYS)
transaction
==== ======================================== =================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHFFLFFFVLXBBL
(END) Dow Jones Newswires
August 11, 2021 07:34 ET (11:34 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Jan 2025 to Feb 2025
Gsk (LSE:GSK)
Historical Stock Chart
From Feb 2024 to Feb 2025
